RBSH
Inspyr Therapeutics Inc

1,479
Mkt Cap
$32.00
Volume
866.00
52W High
$0.0001
52W Low
$0.00
Price
$0.00
RBSH Fundamentals
Prev Close
$0.0001
50D MA
$0.00
Beta
79.21
Avg. Volume
178.57
Loading...
Loading...

About

Rebus Holdings, Inc. is a pharmaceutical company engaged in the research and development of novel therapeutics for the treatment of cancer. Its product pipeline includes Mipsagargin, a dual A2A/A2B antagonist, an A2A antagonist, an A2B antagonist, and an A2A agonist. The company was founded by Craig A. Dionne, John T. Issacs, and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rebus Holdings Inc?
What is the 52-week high for Rebus Holdings Inc?
What was Rebus Holdings Inc stock price yesterday?

Latest RBSH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.